TP53 and glioblastoma: Notably, hsa_circ_0072309 sensitizes GBM cells to TMZ by targeting miR-100/p53 axis and activating autophagy-induced apoptosis, providing a potential avenue to overcome TMZ resistance in GBM treatment [137].